GLAUCOMA SECUNDÁRIO DE ÂNGULO ABERTO - DA FISIOPATOLOGIA AO TRATAMENTO: UM ARTIGO DE REVISÃO
DOI:
https://doi.org/10.36557/pbpc.v3i2.157Keywords:
Glaucoma, Open-Angle, Chronic Secondary Open-Angle Glaucoma, Pathophysiology, Diagnosis, TreatmentAbstract
Introduction: Glaucoma is the leading cause of blindness worldwide, with its prevalence increasing due to the aging population. It is characterized by progressive optic neuropathies, resulting in optic disc cupping, retinal degeneration, and vision loss. Factors such as elevated intraocular pressure (IOP) and abnormal ocular blood flow are related to its pathogenesis. While current treatment focuses on reducing IOP, it only slows disease progression without reversing existing damage. Secondary open-angle glaucoma has various etiologies and requires detailed investigation for effective treatment. Objective: To provide an updated overview of secondary open-angle glaucoma, including its pathophysiological mechanisms and available therapeutic options. Methodology: This research is an integrative literature review. Articles were selected from Medline via PubMed and Scielo databases using the following descriptors: secondary glaucoma, open angle, chronic secondary open-angle glaucoma, pathophysiology, diagnosis and treatment. Review articles, experimental studies, and clinical trials from the past five years were included. After reviewing titles, abstracts, and full texts, five articles remained. Results and Discussion: Analysis of the articles revealed that secondary open-angle glaucoma causes increased IOP, which can lead to optic nerve damage and blindness. The main causes are pseudoexfoliative glaucoma, pigmentary glaucoma, inflammatory glaucoma, and corticosteroid-induced glaucoma. Diagnosis requires careful clinical history and specific tests. Treatment varies according to etiology, with infectious conditions and corticosteroid use potentially elevating IOP, necessitating rigorous treatment and monitoring.Conclusion: Glaucoma, due to its various etiologies, requires identifying the cause to guide treatment—whether through antiviral agents, surgery, or intravitreal anti-VEGF injections—in order to reduce intraocular pressure (IOP) and prevent damage to the optic nerve. Given the irreversibility of the damage, early detection and treatment are crucial.
Downloads
References
ABOUZEID, H.; SINTZOFF, L. Corticostéroïdes et glaucome. Revue Médicale Suisse, v. 19, n. 820, p. 643–647, 2023.
ALDAAS, K. et al. Infections and glaucoma. Survey of OphthalmologyElsevier Inc., , 1 maio 2022.
GRESLECHNER, R.; HELBIG, H. Sekundärglaukome im Rahmen retinaler Erkrankungen. Klinische Monatsblätter für Augenheilkunde, v. 239, n. 09, p. 1111–1118, 14 set. 2022.
GRESLECHNER, R.; HELBIG, H.; SPIEGEL, D. Sekundäre Offenwinkelglaukome: uveitische Sekundärglaukome, Steroidglaukom, posttraumatische/postoperative Glaukome, tumorbedingte Glaukome und Glaukome im Rahmen eines erhöhten episkleralen Venendrucks. Der Ophthalmologe, v. 119, n. 5, p. 533–546, 26 maio 2022.
KANG, J. M.; TANNA, A. P. Glaucoma. Medical Clinics of North AmericaW.B. Saunders, , 1 maio 2021.
KOLIPAKA, G. P.; RAO, A. Secondary glaucoma following vitreo-retinal surgeries. Indian Journal of OphthalmologyWolters Kluwer Medknow Publications, , 1 jan. 2023.
URBONAVIČIŪTĖ, D.; BUTEIKIENĖ, D.; JANULEVIČIENĖ, I. A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment. Medicina, v. 58, n. 12, p. 1870, 18 dez. 2022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Victória Eduarda Cavalcanti de Moraes, Patrícia Lúcia Silva Sampaio Leite, Victor Gomes Rocha, Nichollas Botelho da Fonseca, Milena Figueiredo de Medeiros, Pedro Fellipe Dantas Cordeiro, Samara Silva Noronha Cavalcante, Isabelle Ataíde Correia Lima Brandão, Luiz Eduardo Vanderlei Torres, Mateus Oliveira Carvalho

This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
- Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial.
- Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
- O licenciante não pode revogar estes direitos desde que você respeite os termos da licença.
De acordo com os termos seguintes:
- Atribuição — Você deve dar o crédito apropriado , prover um link para a licença e indicar se mudanças foram feitas . Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.